TrialNeuro-oncology2016

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.

Alba A Brandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.